Smoking Cessation and Reduction in Schizophrenia (SCARIS) with e-cigarette: Study protocol for a randomized control trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Caponnetto, Pasquale ^a,b,c   Polosa, Riccardo ^a,b   Auditore, Roberta ^c   Minutolo, Giuseppe ^b,c   Signorelli, Maria ^b   Maglia, Marilena ^a,b,c   Alamo, Angela ^a,b   Palermo, Filippo ^b   Aguglia, Eugenio ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CTA Villa Chiara Psychiatric Rehabilitation Clinic and Research   (Italy)

Author keywords

Addiction; Cognitive; Electronic cigarette; Quality of life; Schizophrenia clinical trial; Smoking cessation; Smoking reduction

Indexed keywords

ELECTRONIC CIGARETTE;

AGED; ARTICLE; CLINICAL STUDY; COGNITION; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PERCEPTION; PRODUCT SAFETY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SATISFACTION; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION;

ADMINISTRATION, INHALATION; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CLINICAL PROTOCOLS; COGNITION; ELECTRONICS; EQUIPMENT DESIGN; HUMANS; ITALY; NICOTINE; NICOTINIC AGONISTS; PATIENT SATISFACTION; PERCEPTION; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; VOLATILIZATION;

EID: 84899136159     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-88     Document Type: Article

References (24)

1. De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005, 76:1351-1357.
2. Keltner NL, Grant JS. Smoke, smoke, smoke that cigarette. Perspect Psychiatr Care 2006, 42:256-261. 10.1111/j.1744-6163.2006.00085.x, 17107571.
3. Beary M, Hodgson R, Wildgust HJ. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol 2012, 26(5 Suppl):52-61. 10.1177/0269881112440512, 22465947.
4. Aubin HJ, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev 2012, 36:271-284. 10.1016/j.neubiorev.2011.06.007, 21723317.
5. Polosa R, Benowitz NL. Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 2011, 32:281-289. 10.1016/j.tips.2010.12.008, 21256603.
6. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health 2010, 10:231. 10.1186/1471-2458-10-231, 2877672, 20441579.
7. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013, 8:e66317. 10.1371/journal.pone.0066317, 3691171, 23826093.
8. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 2013, 10:446-461. 10.3390/ijerph10020446, 3635154, 23358230.
9. Piper ME, Kenford S, Fiore MC, Baker TB. Smoking cessation and quality of life: changes in life satisfaction over three years following a quit attempt. Ann Behav Med 2012, 43:262-270. 10.1007/s12160-011-9329-2, 3298628, 22160762.
10. Almeida OP, Garrido GJ, Alfonso H, Hulse G, Lautenschlager NT, Hankey GJ, Flicker L. 24-month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage 2011, 55:1480-1489. 10.1016/j.neuroimage.2011.01.063, 21281718.
11. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (E-cigarette) on smoking cessation and reduction: a prospective pilot study. BMC Public Health 2011, 11:786. 10.1186/1471-2458-11-786, 3203079, 21989407.
12. de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Does clozapine decrease smoking?. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:757-762. 10.1016/j.pnpbp.2005.04.031, 15951089.
13. Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 2005, 79:323-335. 10.1016/j.schres.2005.04.016, 15961287.
14. Myles N, Newall HD, Curtis J, Nielssen O, Shiers D, Large M. Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatry 2012, 73:468-475. 10.4088/JCP.11r07222, 22579146.
15. Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim J-C, Love RC, Dixon L. Cigarette smoking and mortality risk in people with Schizophrenia. Schizophr Bull 2011, 37:832-838. 10.1093/schbul/sbp152, 3122289, 20019128.
16. McDonald C. Cigarette smoking in patients with schizophrenia. Br J Psychiatry 2000, 176:596-597.
17. McCreadie RG, Kelly C. Patients with schizophrenia who smoke. Private disaster, public resource. Br J Psychiatry 2000, 176:109. 10.1192/bjp.176.2.109, 10755044.
18. Winterer G. Why do patients with schizophrenia smoke?. Curr Opin Psychiatry 2010, 23:112-119. 10.1097/YCO.0b013e3283366643, 20051860.
19. Segarra R, Zabala A, Eguíluz JI, Ojeda N, Elizagarate E, Sánchez P, Ballesteros J, Gutiérrez M. Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci 2011, 261:241-250. 10.1007/s00406-010-0146-6, 20839003.
20. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 2005, 62:649-659. 10.1001/archpsyc.62.6.649, 15939842.
21. Jubelt LE, Barr RS, Goff DC, Logvinenko T, Weiss AP. Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology (Berl) 2008, 199:89-98. 10.1007/s00213-008-1133-8, 18548234.
22. Ochoa EL, Lasalde-Dominicci J. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking. Cell Mol Neurobiol 2007, 27:609-639. 10.1007/s10571-007-9149-x, 17554626.
23. Williams JM, Ziedonis DM. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behav Healthc 2006, 26:27-31.
24. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2013, 28. CD007253.